Home
Products
• Product Development Focus
• Our Supergenerics Pipeline
• Lead Compound
• Target Identification
• Outlicensing
• Patents
• Alliances/Agreements
Investor Relations
• News Release
• Annual Reports
• Stock Quote
• Corporate Governance
|
Welcome to the official website of Advanomics Corporation | Advanomics Corporation is a leading-edge biopharmaceutical company focused on the research, development and commercialization of drugs and technologies for the treatment of various forms of cancer | Always check our website for new updates...
|
|
About Advanomics
• Corporate Overview
• Corporate History
• Business Focus
• Some Cancer Statistics
• Management
• Careers
• Contact us
• Directors
• Auditors
• Legal counsels
Our Supergenerics Pipeline
Copyright © 2007 Advanomics Corporation
The development of Supergeneric involves “taking a good
drug and making it better” by:
Reducing Toxicity
Improving Efficacy
Enhancing Bioavailability (Oral use, etc…)
We are currently working on improving the performance
of the following cornerstone Anti-Cancer Compounds:
Etoposide
Cisplatin
Carboplatin